These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16006630)

  • 1. Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory.
    Zasadzinski JA; Alig TF; Alonso C; Bernardino de la Serna J; Perez-Gil J; Taeusch HW
    Biophys J; 2005 Sep; 89(3):1621-9. PubMed ID: 16006630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of pulmonary surfactant due to serum-inhibited adsorption and reversal by hydrophilic polymers: experimental.
    Taeusch HW; Bernardino de la Serna J; Perez-Gil J; Alonso C; Zasadzinski JA
    Biophys J; 2005 Sep; 89(3):1769-79. PubMed ID: 15923228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan decreases surfactant inactivation in vitro.
    Lu KW; Goerke J; Clements JA; Taeusch HW
    Pediatr Res; 2005 Feb; 57(2):237-41. PubMed ID: 15585679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary surfactant adsorption is increased by hyaluronan or polyethylene glycol.
    Taeusch HW; Dybbro E; Lu KW
    Colloids Surf B Biointerfaces; 2008 Apr; 62(2):243-9. PubMed ID: 18065212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced surfactant adsorption via polymer depletion forces: a simple model for reversing surfactant inhibition in acute respiratory distress syndrome.
    Stenger PC; Zasadzinski JA
    Biophys J; 2007 Jan; 92(1):3-9. PubMed ID: 17040987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive adsorption: a physical model for lung surfactant inactivation.
    Fernsler JG; Zasadzinski JA
    Langmuir; 2009 Jul; 25(14):8131-43. PubMed ID: 19534502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming rapid inactivation of lung surfactant: analogies between competitive adsorption and colloid stability.
    Zasadzinski JA; Stenger PC; Shieh I; Dhar P
    Biochim Biophys Acta; 2010 Apr; 1798(4):801-28. PubMed ID: 20026298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keeping lung surfactant where it belongs: protein regulation of two-dimensional viscosity.
    Alonso C; Waring A; Zasadzinski JA
    Biophys J; 2005 Jul; 89(1):266-73. PubMed ID: 15833995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient exposure of pulmonary surfactant to hyaluronan promotes structural and compositional transformations into a highly active state.
    Lopez-Rodriguez E; Cruz A; Richter RP; Taeusch HW; Pérez-Gil J
    J Biol Chem; 2013 Oct; 288(41):29872-81. PubMed ID: 23983120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular weight dependence of the depletion attraction and its effects on the competitive adsorption of lung surfactant.
    Stenger PC; Isbell SG; Zasadzinski JA
    Biochim Biophys Acta; 2008 Oct; 1778(10):2032-40. PubMed ID: 18433716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A freeze-fracture transmission electron microscopy and small angle x-ray diffraction study of the effects of albumin, serum, and polymers on clinical lung surfactant microstructure.
    Braun A; Stenger PC; Warriner HE; Zasadzinski JA; Lu KW; Taeusch HW
    Biophys J; 2007 Jul; 93(1):123-39. PubMed ID: 17416614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of mixed monolayers of clinical lung surfactant, serum albumin and hydrophilic polymers.
    Minkov I; Mircheva K; Grozev N; Tz I; Panaiotov I
    Colloids Surf B Biointerfaces; 2013 Jan; 101():135-42. PubMed ID: 22796783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of pulmonary surfactant films adsorbed to an air-liquid interface in vitro.
    Bachofen H; Gerber U; Gehr P; Amrein M; Schürch S
    Biochim Biophys Acta; 2005 Dec; 1720(1-2):59-72. PubMed ID: 16405864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of polymers and KL(4) peptide on surface activity of pulmonary surfactant lipids.
    Lu KW; Taeusch HW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1129-34. PubMed ID: 20188696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons?
    Krafft MP
    Soft Matter; 2015 Aug; 11(30):5982-94. PubMed ID: 26110877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrical surface potential of pulmonary surfactant.
    Leonenko Z; Rodenstein M; Döhner J; Eng LM; Amrein M
    Langmuir; 2006 Nov; 22(24):10135-9. PubMed ID: 17107011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo.
    Lu KW; Taeusch HW; Clements JA
    Exp Lung Res; 2013; 39(4-5):191-200. PubMed ID: 23638643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.